Firstly, thanks for the well wishes. The cyclone is mostly past,...

Firstly, thanks for the well wishes. The cyclone is mostly past, with no damage in my immediate area.

Back to Dr. Tran.

I cannot find any trace of MICROS Infusion System under pending, current or expired US trademarks nor as an FDA cleared or approved medical device.

I note that Dr. Tran’s company. Neurobiogen, was successfully sued by Biogen in 2015 for trademark infringement.

Dr. Tran does indeed have patent applications in his name.

US20220000866 - THERAPEUTIC AGENT COMPOSITION AND METHOD OF USE, FOR TREATMENT OF MILD CONGNITIVE IMPAIRMENT, DEPRESSION, AND PSYCHOLOGICAL DISORDERS is one of them. Use of cPG analogues, including cyclic Glycyl-2-Allyl Proline, as a therapeutic agent for the treatment of these disorders is described. I note that the patent application was ruled as abandoned in 2023.

NA-921 (bionetide) is the drug said to have been successfully tested in a Phase 2/3 trial in Rett syndrome. The name bionetide certainly creates the impression of being a WHO approved INN (such as trofinetide). I’ve checked. It’s not.

NA-921 is said to be a small molecule once-a-day oral capsule based on a novel mechanism of action of GLP-1 and IGF-1 for which the Company has recently filed for patent protection. Its analogue/prodrug has already been approved by the FDA for a certain rare disease, for which the Company is in separate licensing discussions.
https://www.pr.com/press-release/905399